C-C motif chemokine ligand 2 (CCL2) (CCL2)

C-C motif chemokine ligand 2 (CCL2), also known as Monocyte Chemoattractant Protein-1 (MCP-1), is a pivotal proinflammatory cytokine that recruits monocytes, memory T cells, and dendritic cells to sites of injury and infection. By binding to its primary receptor, CCR2, it triggers signaling cascades such as PI3K/Akt and MAPK that regulate cellular migration, survival, and proliferation. In disease contexts, CCL2 plays a critical role in chronic inflammation, organ fibrosis, and the development of an immunosuppressive tumor microenvironment that facilitates cancer metastasis and drug resistance. Therapeutic strategies targeting CCL2 include monoclonal antibodies like carlumab and synthesis inhibitors like bindarit, though clinical success has been hindered by the high degree of redundancy in the chemokine network and rebound effects where ligand levels increase following treatment. Consequently, while it remains a high-interest target for oncology and inflammatory diseases, achieving sustained pharmacological inhibition remains a significant therapeutic challenge.

Other names

Monocyte chemoattractant protein 1MCP-1Small inducible cytokine A2SCYA2Monocyte chemotactic and activating factorMCAFGDCF-2HC11HSMCR30SMC-CF

Neutralization of the chemokine ligand to prevent receptor binding; inhibition of ligand synthesis; disruption of the CCL2/CCR2 signaling axis.